Concepedia

Author

M. J. X. Hillebrand

The Netherlands Cancer Institute

Also Known As

M HILLEBRAND, M Hillebrand, M J Hillebrand, M. J. X. Hillebrand, M.J.X Hillebrand, M.J.X. Hillebrand, Michel Hillebrand, Michel J X Hillebrand, Michel J. Hillebrand, Michel J. X. Hillebrand

83

Publications

3.2K

Citations

32

H-Index

89

Concepts

All Affiliations

The Netherlands Cancer InstituteSlotervaartziekenhuisUtrecht UniversityOncode InstituteUniversity Medical Center Utrecht
MJ

About

M. J. X. Hillebrand is an author at The Netherlands Cancer Institute specializing in medicine, pharmacology, and analytical chemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

32

1.7K

2

Health Sciences

8

8

616

3

Engineering

2

2

43

4

Natural Sciences

2

2

27

5

Public Health

2

2

98

M. J. X. Hillebrand

×

58

Publications

3K

Citations

32

H-Index

YearCitations

Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception

Noam Zelcer, Koen van de Wetering, M. J. X. Hillebrand,

Proceedings of the National Academy of Sciences

2005

214

Brain Accumulation of Dasatinib Is Restricted by P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) and Can Be Enhanced by Elacridar Treatment

Jurjen S. Lagas, Robert A.B. van Waterschoot, Vicky A.C.J. van Tilburg,

Clinical Cancer Research

2009

171

Brain accumulation of sunitinib is restricted by P‐glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration

Seng Chuan Tang, Jurjen S. Lagas, Nienke A. G. Lankheet,

International Journal of Cancer

2011

155

The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry

Elisabeth J. Rook, M. J. X. Hillebrand, Hilde Rosing,

Journal of Chromatography B

2005

136

Pharmacokinetics and Pharmacodynamics of High Doses of Pharmaceutically Prepared Heroin, by Intravenous or by Inhalation Route in Opioid‐Dependent Patients

Elisabeth J. Rook, Jan M. van Ree, Wim van den Brink,

Basic & Clinical Pharmacology & Toxicology

2006

122

Multidrug Resistance Proteins 2 and 3 Provide Alternative Routes for Hepatic Excretion of Morphine-Glucuronides

Koen van de Wetering, Noam Zelcer, Annemieke Kuil,

Molecular Pharmacology

2007

108

Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry

Nienke A. G. Lankheet, M. J. X. Hillebrand, Hilde Rosing,

Biomedical Chromatography

2012

106

Polycyclic aromatic hydrocarbon—DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung

Frederik‐Jan van Schooten, M. J. X. Hillebrand, F.E. van Leeuwen,

Carcinogenesis

1992

100

Determination of Benzo[a]pyrene Diol Epoxide--DNA Adducts in White Blood Cell DNA From Coke-Oven Workers: The Impact of Smoking

Frederik‐Jan van Schooten, F.E. van Leeuwen, M. J. X. Hillebrand,

JNCI Journal of the National Cancer Institute

1990

92

Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients

Frederik‐Jan van Schooten, M. J. X. Hillebrand, F.E. van Leeuwen,

Carcinogenesis

1990

92

Page 1